Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer

Documenti analoghi

• The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
  di: Hubert, A, et al.
  Pubblicazione: (1999)
• Modeling the Probability That Ashkenazi Jewish Women Carry a Founder Mutation in BRCA1 or BRCA2
  di: Hopper, John L., et al.
  Pubblicazione: (1999)
• BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
  di: Solano, Angela R., et al.
  Pubblicazione: (2018)
• BRCA1 mutations in Ashkenazi Jewish women.
  di: Tonin, P, et al.
  Pubblicazione: (1995)
• BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
  di: Moslehi, Roxana, et al.
  Pubblicazione: (2000)